Dry Beans Market is projected to grow from $8.1 billion in 2025 to $12.6 billion by 2035, registering a CAGR of 4.5% during the forecast period (2026–2035). The market growth is driven by increasing global demand for affordable and plant-based protein sources, rising health awareness, and expanding applications of dry beans across both household consumption and industrial food processing sectors. Dry beans remain a staple food product due to their high protein content, long shelf life, and cost-effectiveness, particularly in emerging economies. 

Digital Payments Market is projected to grow from $189.9 billion in 2025 to $1,288.2 billion by 2035, expanding at a compound annual growth rate (CAGR) of 21.1% during the forecast period. The rapid digitisation of financial services, coupled with increasing smartphone penetration and internet accessibility, is driving widespread adoption of digital payment solutions across both developed and emerging economies. A key macro driver accelerating market growth is the expansion of digital connectivity and financial inclusion initiatives worldwide. According to the International Telecommunication Union (ITU), over 5.4 billion people were using the internet globally in 2023, representing nearly 67% of the global population. 

Dairy beverage was valued at $117.1 billion in 2025 and is projected to reach $204.0 billion by 2035, growing at a CAGR of 5.7% from 2026 to 2035. Rising consumer preference for functional nutrition, protein-rich diets, and digestive health beverages is significantly reshaping demand across both developed and emerging economies. A key macro driver supporting market expansion is the rising global focus on nutritional security and on adequate protein intake. According to the Food and Agriculture Organisation (FAO) of the United Nations, dairy remains one of the most efficient and widely consumed sources of high-quality protein, calcium, and essential micronutrients, particularly in developing economies where malnutrition prevention programs are expanding. Additionally, the World Health Organisation (WHO) recommends that adults limit free sugar intake to less than 10% of total energy intake, accelerating demand for low-sugar and functional dairy beverages such as probiotic and high-protein variants.

Conveyors Market is projected to grow from $12.5 billion in 2025 to $22.4 billion by 2035, registering a CAGR of 6.0% during the forecast period. The growth of the market is primarily driven by the increasing demand for automation across manufacturing, logistics, and warehousing sectors. Conveyors play a critical role in improving operational efficiency, reducing manual labour, and enabling high-speed material handling across industries. A key macro driver supporting this growth is the rapid expansion of global manufacturing and industrial output. According to the United Nations Industrial Development Organisation (UNIDO), global manufacturing value added (MVA) grew by approximately 3.3% in 2023, reflecting sustained industrial expansion. Additionally, data from the International Energy Agency (IEA) highlights increasing investments in industrial automation and electrification to enhance productivity and energy efficiency. These trends are directly boosting demand for conveyor systems, particularly in automated production environments.

Cold chain market is valued at approximately $355.2 billion in 2025 and is projected to reach $2,227.9 billion by 2035, expanding at a CAGR of 20.2% during 2026–2035. The market is witnessing steady expansion, driven by increasing demand for temperature-sensitive logistics across food, pharmaceuticals, and chemicals. One of the primary macro drivers accelerating this growth is the rapid expansion of the global pharmaceutical and vaccine supply chain. According to the World Health Organization (WHO), over 16 billion vaccine doses were distributed globally between 2021 and 2023, highlighting the critical need for reliable temperature-controlled logistics infrastructure. Additionally, data from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) indicates that biologics now account for over 30% of the global pharmaceutical pipeline, most of which require strict cold chain handling. This surge in temperature-sensitive therapeutics is directly boosting demand for advanced cold storage, refrigerated transport, and packaging solutions worldwide.

Catechin Market is valued at $1.6 billion in 2025 and is projected to reach $3.2 billion by 2035, expanding at a CAGR of 7.6% during the forecast period. Growth is primarily driven by rising demand for antioxidant-rich nutraceutical ingredients, expanding functional food consumption, and increasing pharmaceutical applications of polyphenols such as catechins. A key macro driver supporting market expansion is the rising global burden of non-communicable diseases (NCDs). According to the World Health Organisation (WHO), NCDs account for approximately 74% of global deaths annually, with cardiovascular diseases being the leading cause. This has significantly accelerated the demand for preventive healthcare solutions, including green tea-derived catechins such as Epigallocatechin Gallate (EGCG), known for antioxidant, anti-inflammatory, and cardioprotective properties.

Carbonated beverage Market is projected to grow from $298.2 billion in 2025 to $438.8 billion by 2035, registering a steady CAGR of 4.0% during the forecast period (2026–2035). The market growth is being driven by rising urbanisation, increasing disposable income, and evolving consumer preferences toward convenience beverages and premium refreshment products. A key macro driver accelerating market expansion is rapid urban population growth and changing consumption habits.

Bio-Implants Market is projected to reach $136.6 billion by 2035, growing from $263.8 billion in 2025 at a steady CAGR of 6.8% during the forecast period. The market growth is primarily driven by the rising prevalence of chronic diseases, increasing ageing population, and advancements in implant technologies across orthopaedic, cardiovascular, and dental applications. One of the key macro drivers fuelling the market is the growing burden of musculoskeletal and cardiovascular diseases globally. According to the World Health Organisation (WHO), musculoskeletal conditions affect approximately 1.71 billion people worldwide, making them the leading contributor to disability.

Biodegradable packaging market is projected to grow significantly from $25.3 billion in 2025 to $56.5 billion by 2035, registering a CAGR of 8.4% during the forecast period. The growth is primarily driven by increasing environmental concerns and stringent government regulations aimed at reducing plastic waste worldwide. One of the key macro drivers accelerating market expansion is the global push toward sustainability and the reduction of single-use plastics. According to the United Nations Environment Programme (UNEP), approximately 400 million tons of plastic waste are generated annually, with less than 10% being recycled. Additionally, the Organisation for Economic Co-operation and Development (OECD) reports that plastic consumption is expected to nearly triple by 2060 if no corrective actions are taken. This alarming trend has compelled governments and industries to shift toward biodegradable alternatives. As a result, industries such as food & beverage, healthcare, and e-commerce are increasingly adopting biodegradable packaging solutions to meet regulatory requirements and consumer preferences for eco-friendly products.

The global antiviral drug market, valued at $61.2 billion in 2025, is projected to grow steadily at a CAGR of 4.0%, reaching approximately $90.6 billion by 2035. The market expansion is driven by rising viral disease burden, advancements in drug development, and increasing global healthcare expenditure. A key macro driver fueling this growth is the escalating prevalence of viral infections worldwide. According to the World Health Organisation (WHO), an estimated 296 million people are living with chronic Hepatitis B, while around 58 million people are infected with Hepatitis C globally. Additionally, approximately 39 million people are living with HIV, necessitating long-term antiviral therapies. These statistics highlight a sustained and growing demand for antiviral treatments across therapeutic areas, directly supporting market expansion.